Different owners need different evidence views.
EU AI ActAI governance lead
This actor needs a clear route from source interpretation to owned evidence, decision, and follow-up for EU AI Act.
legal/regulatory reviewer
This actor needs a clear route from source interpretation to owned evidence, decision, and follow-up for EU AI Act.
product owner
This actor needs a clear route from source interpretation to owned evidence, decision, and follow-up for EU AI Act.
QMS owner
This actor needs a clear route from source interpretation to owned evidence, decision, and follow-up for EU AI Act.
training owner
This actor needs a clear route from source interpretation to owned evidence, decision, and follow-up for EU AI Act.
clinical or operational process owner
This actor needs a clear route from source interpretation to owned evidence, decision, and follow-up for EU AI Act.
Where iFeed can help without overclaiming.
bridge workSource-to-evidence mapping
Convert source material into evidence objects, owners, gaps, and next actions.
Checklist evaluation
Review completed readiness sheets and identify unclear or unsupported claims.
Governance sprint
Create a practical two-week route for inventory, role mapping, evidence review, and update protocol.
Training/workshop
Turn source reading into role-specific literacy and operational confidence.
Current public sources for EU AI Act.
official firstThese links are the public source anchors for this workspace. Interpretation, checklists, and future assets should point back here before being reused outside iFeed.
Regulation (EU) 2024/1689
2024-07-12 · Primary source for articles, definitions, annexes, obligations, and application dates.
European Commission AI Act policy page
Current · Commission implementation context, timeline framing, and policy explanation.
AI literacy questions and answers
Current · Commission-facing practical Q&A for Article 4 AI literacy expectations.
AI Act implementation timeline
Current · Application milestones and phased implementation context for public tracking.